De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ho Wah Genting Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Ho Wah Genting Berhad heeft een totaal eigen vermogen van MYR91.3M en een totale schuld van MYR22.9M, wat de schuld-eigenvermogensverhouding op 25.1% brengt. De totale activa en totale passiva bedragen respectievelijk MYR168.3M en MYR77.0M. De EBIT Ho Wah Genting Berhad is MYR6.1M waardoor de rentedekking 4.9 is. Het heeft contanten en kortetermijnbeleggingen van MYR17.6M.

Belangrijke informatie

25.1%

Verhouding schuld/eigen vermogen

RM 22.89m

Schuld

Rente dekkingsratio	4.9x
Contant	RM 17.57m
Aandelen	RM 91.29m
Totaal verplichtingen	RM 76.97m
Totaal activa	RM 168.26m

Recente financiële gezondheidsupdates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

Recent updates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Jun 18

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Oct 05

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MYR127.9M ) HWGB } overtreffen de korte termijn passiva ( MYR64.1M ).

Langlopende schulden: De kortetermijnactiva HWGB ( MYR127.9M ) overtreffen de langetermijnschulden ( MYR12.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 5.8% ) HWGB wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van HWGB is de afgelopen 5 jaar gedaald van 74.7% naar 25.1%.

Schuldendekking: De schuld van HWGB wordt goed gedekt door de operationele kasstroom ( 81.6% ).

Rentedekking: De rentebetalingen op de schuld van HWGB worden goed gedekt door EBIT ( 4.9 x dekking).

Ho Wah Genting Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Recent updates

Second quarter 2024 earnings released: EPS: RM0.006 (vs RM0.036 loss in 2Q 2023)

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Ho Wah Genting Berhad Appoints Madam Lim Ean Chin as Independent and Non Executive Director

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

First quarter 2024 earnings released: RM0.001 loss per share (vs RM0.036 loss in 1Q 2023)

Ho Wah Genting Berhad Announces the Resignation of Elaine Tan Ai Lin as Independent and Non Executive Chairman of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.007 (vs RM0.01 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

New major risk - Market cap size

New minor risk - Shareholder dilution

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Full year 2022 earnings released: RM0.003 loss per share (vs RM0.009 loss in FY 2021)

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.007 loss in 2Q 2022)

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad has completed a Follow-on Equity Offering in the amount of MYR 2.939792 million.

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad Update on Phase 4 United States Food and Drug Administration Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

New 90-day low: RM0.55

Full year 2020 earnings released: RM0.044 loss per share (vs RM0.019 loss in FY 2019)

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Receives Product Registration Approval for Astramern Astra H Capsule from NPRA for A Period Commencing 14 January 2021 to 14 January 2026

Ho Wah Genting Berhad Enters into Memorandum of Understanding with Chongqing ISIA Bio-Technology Co., Ltd (ISIA) to Manufacture and Produce in Vitro Diagnostic Products

New 90-day low: RM0.59

Ho Wah Genting Berhad Provides Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

New 90-day high: RM0.89

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Third quarter 2020 earnings released: RM0.002 loss per share

Ho Wah Genting Berhad Enters into Memorandum of Understanding with GNOSIS LABORATORIES (M) SDN BHD

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Ho Wah Genting Berhad Announces Appointment as the Authorized Sale Agent/ Distributor for the Covid-19 related products from Wuhan Easy Diagnosis Biomedicine Co.,Ltd

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Ho Wah Genting Berhad Announces Redesignation of Mr. Kenny Yeoh Khi Khen from Independent and Non Executive Member of Risk Committee to Chairman of Risk Committee

First half earnings released

Dato Lim Ooi Hong, Lim Wee Kiat and Datuk Teo Tiew, Executive Directors of Ho Wah Genting Berhad completed the acquisition of remaining 70.24% stake in Ho Wah Genting Berhad (KLSE:HWGB).

New 90-day high - RM0.60

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven